- 1. 14-3-3 Family
- [The 14-3-3 family of proteins mediates signal transduction by binding to phosphoserine-containing proteins. Two different binding motifs, RSXpSXP and RXY/FXpSXP, are present in nearly all known 14-3-3 binding proteins. The14-3-3 dimer binds tightly to single molecules containing tandem repeats of phosphoserine motifs, implicating bidentate association as a signaling mechanism with molecules such as Raf, BAD, and Cbl. (from OMIM) ( NCI )] (UMLS (NCI) C1337047) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 51. FACIAL NERVE INJ-BIRTH
- [ ] (UMLS (ICD9CM) C0391999) =Injury or Poisoning ;
|
- 2. 2-F-ara-AMP
- [The phosphate salt of fludarabine, a synthetic purine nucleoside antimetabolite with antineoplastic activity. Preferentially transported into malignant cells and metabolized to its active form 2-fluoro-ara-ATP by deoxycytidine kinase, fludarabine inhibits alpha DNA polymerase and RNA reductase and competes with deoxyadenosine triphosphate, resulting in inhibition of DNA primase, inhibition of DNA synthesis, and cell death. (NCI04) ( NCI )] (UMLS (NCI) C0060483) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =2-Fluoro-9-beta-arabinofuranosyladenine;
=FLUDARABINE PHOSPHATE 50 MG;
| - 52. facial nerve motor nucleus
- [ ] (UMLS (CSP) C0175442) =Body Part, Organ, or Organ Component
|
- 3. F-actin
- (UMLS (NCI) C1180307) Filamentous Actin =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 53. Facial Nerve Neoplasm
- (UMLS (NCI) C1263899) Facial Nerve Neoplasms;
Facial Nerve Tumor;
Facial Nerve Tumors;
Neoplasm of Facial Nerve;
Neoplasm of Seventh Cranial Nerve;
Neoplasm of the Facial Nerve;
Neoplasm of the Seventh Cranial Nerve;
Seventh Cranial Nerve Neoplasm;
Seventh Cranial Nerve Neoplasms;
Seventh Cranial Nerve Tumor;
Seventh Cranial Nerve Tumors;
Tumor of Facial Nerve;
Tumor of Seventh Cranial Nerve;
Tumor of the Facial Nerve;
Tumor of the Seventh Cranial Nerve;
VIIth Cranial Nerve Neoplasms;
VIIth Cranial Nerve Tumors;
=Neoplastic Process |
- 4. FA
- [A B-complex vitamin that is being studied as a cancer prevention agent. Also called folate. ( NCI )] (UMLS (NCI) C0016410) =Organic Chemical; Pharmacologic Substance; Vitamin =pterin;
[VT100] VITAMIN B;
[VT102] FOLIC ACID/LEUCOVORIN;
=Tetrahydrofolates;
CARNATION INSTANT BREAKFAST PWDR,35.8GM;
CRITICARE HN LIQUID;
NURSOY LIQUID;
S-M-A IRON FORTIFIED,INFANT FORMULA CONC,ORAL;
S-M-A IRON FORTIFIED,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA CONC,ORAL;
S-M-A LO-IRON,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA PWDR;
SUSTAGEN PWDR CHOCOLATE;
THICKENUP POWDER;
ULTRACAL TUBE-FEEDING LIQUID; More… | - 54. Facial Nerve Nucleus
- (UMLS (NCI) C0228740) =Body Part, Organ, or Organ Component
|
- 5. FA/LMTX
- (UMLS (NCI) C0281730) =Therapeutic or Preventive Procedure
| - 55. Facial Nerve Paralysis
- [severe or complete loss of facial muscle motor function; this condition may result from central or peripheral lesions; damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles; facial nerve diseases generally results in generalized hemifacial weakness; neuromuscular junction diseases and muscular diseases may also cause facial paralysis. ( CSP )] (UMLS (NCI) C0015469) =Disease or Syndrome =Mouth Diseases;
DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM;
paralysis;
|
- 6. FAA/IL-2
- (UMLS (NCI) C0280503) =Therapeutic or Preventive Procedure ;
| - 56. Facial paralysis/Bells palsy
- [A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376)(MSH)] (UMLS (ICPC) C0376175) (Facial paralysis/Bells palsy; AURPEGI PARALISIA; Facialisparese/Bell's parese; Facialis parese/Bell's palsy; KASVOHERMOHALVAUS/BELLIN PAREESI; Paralysie faciale/de Bell; Facialisparese, Bell'sche Laehmung; shituk panim-'BELL; facialis paresis; Paralisi facciale/paralisi di Bell; ANSIKTSLAMMELSE/FACIALISPARES - g51 + g53.R; Paralisia facial/de Bell; Paralisis facial/de Bell; ANSIKTSFORLAMNING/BELLS PARES) =Disease or Syndrome ;
=FACIAL NERVE DIS NOS; Herpesviridae disease; Mouth Diseases; neurologic; Diagnosis/Diseases Component; |
- 7. Fab domain
- [ ] (UMLS (CSP) C0598667) =Amino Acid Sequence ;
| - 57. Facial Plastic Surgery
- (UMLS (HL7) C1555802) =Intellectual Product =Otolaryngology;
|
- 8. FAB L2
- (UMLS (NCI) C0023453) =Neoplastic Process ;
=acute lymphatic leukemia;
| - 58. facial reconstruction
- [ ] (UMLS (CSP) C1537014) =Therapeutic or Preventive Procedure
|
- 9. Fabavirus
- [A genus of the family COMOVIRIDAE with a wide host range among dicotyledons and some monocotyledons. They are transmitted nonpersistently by aphids. The type species is broad bean wilt virus 1. ( MSH )] (UMLS (CSP) C0376458) =Virus
| - 59. FACIAL RHYTIDECTOMY
- [Plastic surgery performed, usually by excision of skin, for the elimination of wrinkles from the skin. ( MSH )] (UMLS (ICD9CM) C0035519) =Therapeutic or Preventive Procedure
|
- 10. FABMS
- [mass spectrometry technique to determine chemical structure. ( CSP )] (UMLS (CSP) C0080171) =Diagnostic Procedure; Research Activity ;
=Mass Spec;
| - 60. Facial Vein
- (UMLS (NCI) C0226532) =Body Part, Organ, or Organ Component
|
- 11. FABP Family Gene
- [These genes encode the intracellular fatty acid-binding proteins (FABPs). Fatty acid metabolism in mammalian cells depends on a flux of fatty acids, between the plasma membrane and mitochondria or peroxisomes for beta-oxidation, and between other cellular organelles for lipid synthesis. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and at least 3 different FABPs play a role as transport vehicles of these hydrophobic compounds throughout the cytoplasm. They may participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. (from LocusLink 2170) ( NCI )] (UMLS (NCI) C1333529) =Gene or Genome ;
| - 61. FACIAL WEAKNESS
- (UMLS (ICD9CM) C0427055) =Sign or Symptom
|
- 12. FABP1
- [Fatty Acid-Binding Protein 1, encoded by the FABP1 gene, is the fatty acid binding protein found in liver. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. This protein binds free fatty acids and their coenzyme a derivatives, bilirubin, and some other small molecules in the cytoplasm. It may be involved in intracellular lipid transport. (from LocusLink and Swiss-Prot) ( NCI )] (UMLS (NCI) C0078741) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 62. FACILIT INTRAOC CIRC NEC
- (UMLS (ICD9CM) C0079953) =Therapeutic or Preventive Procedure ;
|
- 13. FABP1
- [This gene plays a role in fatty acid metabolism in the liver. ( NCI )] (UMLS (NCI) C1333524) FABP1 Gene;
Fatty Acid Binding Protein 1, Liver Gene =Gene or Genome | - 63. Facilitation of intraocular circulation
- [ ] (UMLS (ICD9CM) C0197540) =Therapeutic or Preventive Procedure
|
- 14. FABP2
- [Fatty Acid-Binding Protein 2, encoded by the FABP2 gene, belongs to the fatty-acid binding protein (FABP) family thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. Intestinal fatty acid-binding protein 2 gene contains four exons and is an abundant cytosolic protein in small intestine epithelial cells. The FABP2 gene has a polymorphism in position 54, which changes Ala-54 (71% of the population) to Thr-54 (29%). The Thr-54 allele has a 2-fold greater affinity for long-chain fatty acids than the Ala-54 allele. Thr-54 is associated with increased fat oxidation and insulin resistance. (from LocusLink and Swiss-Prot) ( NCI )] (UMLS (NCI) C1173118) FABPI;
Fatty Acid Binding Protein 2, Intestinal;
Fatty Acid-Binding Protein 2;
Fatty Acid-Binding Protein, Intestinal;
I-FABP;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
◊ [This gene plays a role in fatty acid metabolism in the intestine. ( NCI )] (UMLS (NCI) C1333525) FABP2 Gene; Fatty Acid Binding Protein 2, Intestinal Gene Gene or Genome ; | - 64. facility design
- [ ] (UMLS (CSP) C0015473) =Occupational Activity
|
- 15. FABP3
- [Encoded by human FABP3 Gene (FABP/P2/CRBP/CRABP Transporter Family), Fatty Acid-Binding Protein 3 is a 132-amino acid 14.7 kD protein. Demonstrated in liver, heart, intestine, skeletal muscle, and brain, cytoplasmic FABPs are involved in uptake, intracellular metabolism, and/or transport of long-chain fatty acids and their acyl-CoA esters. Fatty Acid-Binding Protein 3 is likely involved in intracellular fatty acid transport, arrests the growth of mammary epithelial cells, and is involved in mammary gland differentiation. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1312696) Fatty Acid Binding Protein 11;
Fatty Acid Binding Protein 3, Muscle And Heart (Mammary-Derived Growth Inhibitor);
Fatty Acid-Binding Protein 3;
Fatty Acid-Binding Protein 3, Muscle;
Fatty Acid-Binding Protein, Heart;
Fatty Acid-Binding Protein, Muscle And Heart;
Fatty Acid-Binding Protein, Skeletal Muscle;
Heart Fatty Acid-Binding Protein;
H-FABP;
Mammary-Derived Growth Inhibitor;
MDGI;
M-FABP;
Muscle Fatty Acid-Binding Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
◊ [This gene plays a role in fatty acid metabolism, but is critical for the growth arrest of mammary epithelial cells. In addition, this gene is a candidate tumor suppressor gene for human breast cancer. ( NCI )] (UMLS (NCI) C1333526) FABP3 Gene; Fatty Acid Binding Protein 3, Muscle and Heart (Mammary-Derived Growth Inhibitor) Gene Gene or Genome ; | - 65. Facility ID
- (UMLS (HL7) C1549700) =Idea or Concept =Identifier type;
HL7 Vocabulary Version 2.5 |
- 16. FABP4
- [Fatty Acid-Binding Protein 4, encoded by the FABP4 gene, is a fatty acid binding protein found in adipocytes. This protein binds both long chain fatty acid and retinoic acid and is involved in lipid transport protein in adipocytes. (from LocusLink and Swiss-Prot) ( NCI )] (UMLS (NCI) C1312689) Fatty Acid-Binding Protein 4 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
◊ [This gene plays a role in the regulation of intracellular transport and in fatty acid metabolism. ( NCI )] (UMLS (NCI) C1333527) FABP4 Gene; Fatty Acid Binding Protein 4, Adipocyte Gene Gene or Genome ; | - 66. facility renovation
- [ ] (UMLS (CSP) C0920511) =Occupational Activity
|
- 17. FABP5
- [This gene plays a role in a variety of processes including fatty acid metabolism, uptake, and transport. ( NCI )] (UMLS (NCI) C1333528) FABP5 Gene;
Fatty Acid Binding Protein 5 (Psoriasis-Associated) Gene =Gene or Genome ;
| - 67. Facility type
- (UMLS (HL7) C1547726) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Agent for a foreign manufacturer;
Manufacturer;
User;
Distributor |
- 18. fabric
- [ ] (UMLS (CSP) C0039717) =Manufactured Object
| - 68. facioscapulohumeral muscular dystrophy
- [An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420) ( MSH )] (UMLS (CSP) C0238288) =Disease or Syndrome =HERED PROG MUSC DYSTRPHY;
|
- 19. Fabrol
- (UMLS (NCI) C0591477) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 69. FACS
- [ ] (UMLS (CSP) C0598442) =Medical Device
|
- 20. face
- [front of the human head from the forehead to the chin and ear to ear. ( CSP )] (UMLS (CSP) C0015450) =Body Location or Region ;
=head;
Body Part | - 70. FACS
- [Selection and deposition of individual cells of a particular phenotype from a mixed population into a separate tube or tissue culture plate by the use of a fluorescence-activated cell sorter (FACS) and fluorescently-labeled antibodies specific for surface molecules on the cells to be sorted. ( NCI )] (UMLS (NCI) C0079366) =Laboratory Procedure ;
|
- 21. FACE & NECK INJURY
- [ ] (UMLS (ICD9CM) C0272422) =Injury or Poisoning
| - 71. facsimile
- [ ] (UMLS (CSP) C0599936) =Machine Activity ;
|
- 22. face cancer
- [ ] (UMLS (CSP) C1654949) =Neoplastic Process
| - 72. Facsimile data
- (UMLS (HL7) C1548452) =Intellectual Product ;
=Subtype of referenced data;
|
- 23. face expression
- [observable changes of expression in the face in response to emotional stimuli. ( CSP )] (UMLS (CSP) C0015457) =Finding ;
=nonverbal communication;
| - 73. FACTITIOUS DIS W SYMPTOM
- (UMLS (ICD9CM) C0015481) =Mental or Behavioral Dysfunction
|
- 24. Face Injury
- [General or unspecified injuries to the soft tissue or bony portions of the face. ( MSH )] (UMLS (NCI) C0015459) =Injury or Poisoning ;
=Craniocerebral Trauma;
=Eye Injuries;
Maxillofacial Injuries | - 74. FACTITIOUS ILL NEC/NOS
- [ ] (UMLS (ICD9CM) C0154456) =Mental or Behavioral Dysfunction
|
- 25. face neoplasm
- [ ] (UMLS (CSP) C0015461) =Neoplastic Process =Head and Neck Neoplasm;
=eyelid cancer;
| - 75. Factive
- (UMLS (NCI) C1320102) =Organic Chemical; Antibiotic
|
- 26. Face or brow presentation of fetus
- [ ] (UMLS (ICD9CM) C0156940) =Finding
| - 76. Factor II Deficiency
- [absence or reduced levels of prothrombin in the blood. ( CSP )] (UMLS (NCI) C0020640) =Disease or Syndrome =blood coagulation disorder;
HEMORRHAGIC COND NOS;
Genetic Condition;
Coagulation Protein Disorders |
- 27. Face or brow presentation, antepartum
- [ ] (UMLS (ICD9CM) C0156943) =Finding
| - 77. factor P
- [a non-immunoglobulin, gammaglobulin complement of the alternative pathway; it complexes with C3b and stabilizes alternative pathway C3 convertase. ( CSP )] (UMLS (CSP) C0033452) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=gamma globulin;
|
- 28. Face or brow presentation, delivered
- [ ] (UMLS (ICD9CM) C0156942) =Finding
| - 78. Factor VIII Related Antigen
- [Human von Willebrand factor, a 270 kD multimeric plasma glycoprotein, has functional binding domains to platelet glycoprotein Ib, glycoprotein Iib/IIIa, collagen and heparin. It mediates platelet adhesion to injured vessel walls and serves as a carrier and stabiliser for coagulation factor VIII. It is expressed in endothelial cells, platelets, megakaryocytes and a number of tumors. (NCI) ( NCI )] (UMLS (NCI) C0015513) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 29. Face or brow presentation, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156941) =Finding
| - 79. Factor XII Deficiency
- [An absence or reduced level of blood coagulation factor XII. It normally occurs in the absence of patient or family history of hemorrhagic disorders and is marked by prolonged clotting time. ( MSH )] (UMLS (NCI) C0015526) =Disease or Syndrome =HEMORRHAGIC COND NOS;
Coagulation Protein Disorders |
- 30. face-to-face
- [Participation by voice communication where parties speak to each other directly. ( HL7V3.0 )] (UMLS (HL7) C1553514) =Idea or Concept =verbal;
| - 80. factor XIIIa
- [Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation of the fibrin polymer (clot) culminating the blood coagulation cascade. ( MSH )] (UMLS (CSP) C0015533) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 31. Facet Joint
- [A synovial joint between the superior articular process of one vertebra and the inferior articular process of the one adjacent. ( NCI )] (UMLS (NCI) C0224521) =Body Space or Junction
| - 81. Factrel
- (UMLS (NCI) C0306166) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 32. Facial Artery
- (UMLS (NCI) C0226109) =Body Part, Organ, or Organ Component
| - 82. faculty
- [The body of teachers and administrators at a school. ( NCI )] (UMLS (CSP) C0015535) =Professional or Occupational Group
|
- 33. FACIAL BONE DX PROC NEC
- [ ] (UMLS (ICD9CM) C0177299) =Diagnostic Procedure
| - 83. FAD
- [coenzyme composed of riboflavin 5'-phosphate and adenosine 5'-phosphate linked by a pyrophosphate bond; it forms the prosthetic group of many flavoprotein enzymes, serving as an electron carrier by being alternately oxidized (FAD) and reduced (FMNH2); important in electron transport in mitochondria and the endoplasmic reticulum. ( CSP )] (UMLS (CSP) C0015540) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=ribonucleotide;
cofactor |
- 34. FACIAL BONE INCISION NEC
- [ ] (UMLS (ICD9CM) C0177296) =Therapeutic or Preventive Procedure
| - 84. FADD
- [Acts as an adaptor protein, interacting with FAS or TNFR-2. The death domain of these receptors binds to the corresponding domain of FADD, which in turn recruits the zymogen form of the death protease FLICE, activating a protease cascade which results in apoptosis. ( NCI )] (UMLS (NCI) C0296346) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 35. FACIAL BONE RECONSTR NEC
- [ ] (UMLS (ICD9CM) C0177307) =Therapeutic or Preventive Procedure
| - 85. FADD
- [This gene is involved in signal transduction and the activation of caspase-dependent apoptosis. ( NCI )] (UMLS (NCI) C1333530) FADD Gene;
Fas (TNFRSF6)-Associated via Death Domain Gene =Gene or Genome ;
|
- 36. FACIAL BONE REPAIR NEC
- [ ] (UMLS (ICD9CM) C0177315) =Therapeutic or Preventive Procedure
| - 86. Faeroe Islands
- [An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway. (NCI) ( NCI )] (UMLS (NCI) C0015541) =Geographic Area
|
- 37. FACIAL BONE SEQUESTRECT
- [ ] (UMLS (ICD9CM) C0185565) =Therapeutic or Preventive Procedure
| - 87. FAIL FORCEPS NOS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157230) =Disease or Syndrome
|
- 38. FACIAL BONE X-RAY NEC
- [ ] (UMLS (ICD9CM) C0177726) =Diagnostic Procedure
| - 88. FAIL INDUCT NOS-ANTEPART
- [ ] (UMLS (ICD9CM) C0157174) =Disease or Syndrome
|
- 39. Facial bone, inferior nasal concha
- (UMLS (HL7) C1550255) =Body Part, Organ, or Organ Component =Body Part;
| - 89. FAIL INDUCTION NOS-DELIV
- [ ] (UMLS (ICD9CM) C0157173) =Disease or Syndrome
|
- 40. Facial bone, lacrimal
- (UMLS (HL7) C1550256) =Body Part, Organ, or Organ Component =Body Part;
| - 90. FAIL INDUCTION NOS-UNSP
- [ ] (UMLS (ICD9CM) C0157172) =Disease or Syndrome
|
- 41. Facial bone, maxilla
- (UMLS (HL7) C1561526) =Body Part, Organ, or Organ Component =Body Part;
| - 91. FAIL INTROD/REMOVE TUBE
- [ ] (UMLS (ICD9CM) C0261573) =Injury or Poisoning
|
- 42. Facial bone, nasal
- (UMLS (HL7) C1550257) =Body Part, Organ, or Organ Component =Body Part;
| - 92. FAIL MECH INDUCT-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157170) =Disease or Syndrome
|
- 43. Facial bone, palatine
- (UMLS (HL7) C1550258) =Body Part, Organ, or Organ Component =Body Part;
| - 93. FAIL MECH INDUCT-DELIVER
- [ ] (UMLS (ICD9CM) C0157169) =Finding
|
- 44. Facial bone, vomer
- (UMLS (HL7) C1550259) =Body Part, Organ, or Organ Component =Body Part;
| - 94. FAIL MECHAN INDUCT-UNSP
- [ ] (UMLS (ICD9CM) C0157168) =Disease or Syndrome
|
- 45. Facial bone, zygomatic
- (UMLS (HL7) C1550260) =Body Part, Organ, or Organ Component =Body Part;
| - 95. FAIL STERILE CATHETER
- [ ] (UMLS (ICD9CM) C0261539) =Injury or Poisoning
|
- 46. FACIAL BONE/JNT OP NEC
- [ ] (UMLS (ICD9CM) C0175618) =Therapeutic or Preventive Procedure
| - 96. FAIL STERILE ENDOSCOPY
- [ ] (UMLS (ICD9CM) C0497082) =Injury or Poisoning
|
- 47. facial muscle
- [muscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. ( CSP )] (UMLS (CSP) C0015460) =Body Part, Organ, or Organ Component ;
=Striated Muscle;
| - 97. FAIL STERILE HEART CATH
- [ ] (UMLS (ICD9CM) C0497083) =Injury or Poisoning
|
- 48. FACIAL NERVE DIS NEC
- [ ] (UMLS (ICD9CM) C0029616) =Disease or Syndrome
| - 98. FAIL STERILE INJECTION
- [ ] (UMLS (ICD9CM) C0497081) =Injury or Poisoning
|
- 49. FACIAL NERVE DIS NOS
- [Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation. ( MSH )] (UMLS (ICD9CM) C0015464) =Disease or Syndrome =CRANIAL NERVE DIS NOS;
=Facial Hemiatrophy;
Facial Neuralgia;
GENICULATE HERPES ZOSTER;
Melkersson-Rosenthal Syndrome;
Facial Nerve Injuries;
Mobius Syndrome;
ANSIKTSFORLAMNING/BELLS PARES;
| - 99. FAIL STERILE PERFUSN NEC
- [ ] (UMLS (ICD9CM) C0261536) =Finding
|
- 50. Facial Nerve Ganglion
- [The sensory ganglion of the facial (7th cranial) nerve. The geniculate ganglion cells send central processes to the brain stem and peripheral processes to the taste buds in the anterior tongue, the soft palate, and the skin of the external auditory meatus and the mastoid process. ( MSH )] (UMLS (NCI) C0017406) =Body Part, Organ, or Organ Component
| - 100. FAIL STERILE PROCED NEC
- [ ] (UMLS (ICD9CM) C0261541) =Finding
|
home
